Reuters Events Pharma’s Post

Innovate, Compete, Thrive.   I thoroughly enjoyed championing the pharmaceutical sector – the crown jewel of the European industry – at the European Health Summit 2024.    I believe in a Europe where the next generation of therapies is developed and produced right here, transforming lives and driving economic growth. To make this vision a reality, we must:  ✅ Recognize life sciences as a strategic priority ✅ Boost commercial competitiveness ✅ Attract and retain top talent   For Bayer, with over 160 years in Europe, this is more than a policy discussion. It’s a call to action. We need a robust industrial strategy to keep Europe at the forefront of medical innovation and healthcare autonomy.   Now actions must follow words. We have no time to lose in making Europe the destination for life sciences excellence and secure a thriving future for patients, innovators, and industries alike.   Thanks for the great discussion Dolors Montserrat, Huber Gambs, Gilles Marrache, Dr. Malina Müller and Jacki Davis. #ehs2024

Join us at #DPEast for the panel "Restructuring Again? Redefine Skills, Capabilities, and Operating Models to Build a Sustainable, Successful Marketing Framework for the Future." REGISTER NOW! Don't miss out on this session: https://ow.ly/7M9C50SOmEU 💡What to Expect: 👉Examine the shift from linear to more collaborative, cross-stakeholder processes throughout the entire marketing lifecycle 👉Explore the evolving structure of pharma companies and strategies for staying agile and adapting to change management to foster growth 👉Who will be the decision-makers and how will decisions be made under these new operating models? 👉How does the changing pharma framework impact agency/solution provider and pharma relationship? Check out more Featured Sessions: https://ow.ly/rffB50SOmg6 A big thank you to our Moderators & Speakers for this Panel: - Robert (Bob) Allen from Bristol Myers Squibb - Kate Greengrove from GSK - Brian Cantwell from Bayer - Annemarie Carpico Jazz Pharmaceuticals (EUSA Pharma USA) Inc. - Kara Reheis from Daiichi Sankyo Stay Updated by following Fierce Life Sciences Events & Digital Pharma Series #DigitalPharma #PharmaMarketing #PharmaLeadership #HealthcareStrategies #WeAreFierce #FierceBiotech #FierceHealth #FiercePharma

This month we are pleased to share an interview published in the The Irish Times as part of our commitment to the Pharma Industry Awards, where we serve as 'Impact Ambassador for Digital Innovation.' The Q&A includes insights from David Sheedy, Head of Life Sciences Manufacturing Ireland, and David Staunton, Head of Transformation for Cognizant, and discusses the latest trends and challenges in pharma manufacturing. Our leaders highlight the critical role of digital innovation and technology in driving industry advancements, emphasizing the importance of a data-centric approach to improve the economics of drug manufacturing. The interview also explores the potential of hashtag#generativeAI to make personalized therapies more accessible and affordable, along with the factors contributing to genuine innovation in the field. Additionally, they discuss ongoing digital transformation in the industry, driven by technology integration, and offer a forward-looking perspective on the emerging technologies set to shape the next decade. Read the full interview here: https://cogniz.at/3BPplIr #digitalinnovation #pharmaindustryawards #irelandpharma

Thank you to our panel for a thought-provoking discussion on the impact of clinical outcomes on Emerging Biopharma company valuation. We reviewed insights and implications from the forthcoming IQVIA white paper 'Value Inflection,' which focuses on this very topic. Stay tuned for more valuable information on how clinical outcomes can affect your company's value #clinicaloutcomes #companyvaluation #IQVIA #ValueInflection

Building a strong foundation isn't just about collecting data. It's about uncovering Human Truth. Join our very own Christopher Hoel, and Robyn Shawkey of GSK at #PRMC2025 on Thursday, 2/6 at 9:20AM EST – Track C, to discover how deep human understanding accelerates product launches and drives sustained success in pharma. #Brandtrust #Insights #ConsumerInsights #DeepInsights #HumanTruth

📢 Exciting news! ✨ We’re proud to attend the Pharma CIMICON Conference 2024 in Berlin from October 6-8. 👩💻 Join us as we explore the latest trends and strategies shaping the future of competitive intelligence in pharma. 📅 Mark your calendars and connect with industry leaders, innovators, and experts. Don’t miss out! #PharmaCIMI #CIMICON2024 #PharmaInnovation #pharmacimicon #PharmaCiMicon2024 #conference2024 #pharmaconference #pharmanews #CompetitiveIntelligence #BerlinConference #vyuhgenics #vyuhpharma #HealthcareLeadership

As we kick off #biopharma's biggest year yet at the J.P. Morgan Healthcare Conference (Jan 13-16, 2025), one thing is clear: the landscape is rapidly evolving. Will you be at the tip of the spear, shaping the future, or reacting to the moves of others? Molekule Consulting empowers client partners with ethical, actionable, #HUMINT-derived #strategic intelligence – the foresight to anticipate market shifts, understand competitor strategies at their deepest levels, and make decisive, informed decisions that drive unparalleled commercial success. For the past 13 years, we have partnered with leading multinational biopharma companies, providing the intelligence foundation for their most critical strategic initiatives. Imagine having access to insights that illuminate not just what your competitors are doing, but why they are doing it. Molekule provides this unique perspective, allowing you to anticipate, adapt, and gain a decisive advantage. Our expertise provides a 360-degree view of your competitive landscape, from pre-launch planning to lifecycle management, giving you the power to: **Enter the market with a go-to-market strategy built on unparalleled intelligence, ensuring a launch trajectory that surpasses expectations. **Proactively anticipate and counter competitive threats, turning potential challenges into opportunities for growth. **Gain a granular understanding of key opinion leaders, payer dynamics, and evolving market access landscapes to inform your strategic decisions. **Develop robust, adaptable commercialization plans that secure your long-term market presence and maximize the value of your assets. At #JPM2025, let's explore the possibilities. Let's discuss how Molekule can provide the strategic intelligence foundation for your continued success in this dynamic market. DM David Alderman or comment below to schedule a meeting. #JPMHC #JPM2025 #Biotech #Pharma #StrategicIntelligence #CompetitiveIntelligence #Commercialization #MarketAccess #HUMINT

As we kick off #biopharma's biggest year yet at the J.P. Morgan Healthcare Conference (Jan 13-16, 2025), one thing is clear: the landscape is rapidly evolving. Will you be at the tip of the spear, shaping the future, or reacting to the moves of others? Molekule Consulting empowers client partners with ethical, actionable, #HUMINT-derived #strategic intelligence – the foresight to anticipate market shifts, understand competitor strategies at their deepest levels, and make decisive, informed decisions that drive unparalleled commercial success. For the past 13 years, we have partnered with leading multinational biopharma companies, providing the intelligence foundation for their most critical strategic initiatives. Imagine having access to insights that illuminate not just what your competitors are doing, but why they are doing it. Molekule provides this unique perspective, allowing you to anticipate, adapt, and gain a decisive advantage. Our expertise provides a 360-degree view of your competitive landscape, from pre-launch planning to lifecycle management, giving you the power to: **Enter the market with a go-to-market strategy built on unparalleled intelligence, ensuring a launch trajectory that surpasses expectations. **Proactively anticipate and counter competitive threats, turning potential challenges into opportunities for growth. **Gain a granular understanding of key opinion leaders, payer dynamics, and evolving market access landscapes to inform your strategic decisions. **Develop robust, adaptable commercialization plans that secure your long-term market presence and maximize the value of your assets. At #JPM2025, let's explore the possibilities. Let's discuss how Molekule can provide the strategic intelligence foundation for your continued success in this dynamic market. DM David Alderman or comment below to schedule a meeting. #JPMHC #JPM2025 #Biotech #Pharma #StrategicIntelligence #CompetitiveIntelligence #Commercialization #MarketAccess #HUMINT

New Year, New Opportunities in #Biopharma: Welcome to 2025 The J.P. Morgan Healthcare Conference (Jan 13–16, 2025) is just around the corner, setting the stage for a pivotal year in our industry. Will you be leading the charge—shaping the future—or reacting to everyone else’s moves? At Molekule Consulting Consulting, we’ve spent 13 years empowering global #biopharma partners with ethical, actionable strategic intelligence derived from #HUMINT (Human Intelligence). We help you understand not just what your competitors are doing, but why—so you can adapt faster and more decisively. Our 360-degree approach covers everything from pre-launch strategy to lifecycle management, empowering you to: * Launch with unstoppable momentum: Leverage precise market intelligence to maximize your impact from day one. * Outmaneuver the competition: Transform potential challenges into growth catalysts by anticipating their next moves. * Navigate complex markets: Gain clarity on market access dynamics, KOL influence, and payer landscapes. * Maximize asset value: Develop robust commercialization plans built for long-term success. For example, we recently conducted competitive strategic benchmarking for a multinational biopharma company evaluating a high-value bolt-on acquisition. By analyzing competitor activity and strategic intent, we identified key synergies and potential risks that significantly informed their due diligence process and ultimately contributed to a successful acquisition strategy. As the New Year kicks off, there’s no better time to position yourself for success at the J.P. Morgan Healthcare Conference. Join us at #JPM2025 to discover how our strategic intelligence can give you a decisive competitive edge. DM David Alderman or comment below to schedule a meeting at #JPMHC. Let’s shape the future of biopharma—together. #JPM2025 #Biotech #Pharma

Let’s dig into the future, because waiting isn’t an option. Digg in Pharma Europe isn’t just a course, it’s a call to lead. A 100% online live program for those ready to step forward, ask the tough questions, and drive real change. This program was built to spark curiosity, ambition, and bold thinking. From Basel, the heart of European pharma, we’re here to challenge the status quo and empower leaders who want to make an impact that matters. If that sounds like you, let’s get started. 👉 https://lnkd.in/dXeC2mYG #GenHKnowledge #DiggInPharmaEurope #ExecutiveEducation #Pharma #Health